We equip global pharmaceutical and biotech companies with tailored competitive intelligence and deep market insight, enabling teams to anticipate competitive actions, understand market changes and act with confidence.
Our Competitive Intelligence team, previously known as Pennside, brings a long-standing reputation for delivering high-quality, actionable insight.
Our team brings deep subject matter expertise from seasoned competitive intelligence specialists with decades of experience, underpinned by AI-enhanced, advanced technology to deliver consistent, high-quality insight.
Build a clear understanding of disease landscapes, competitive dynamics, and pipeline evolution to support confident strategic and scientific decision-making.
Go beyond data collection with expert-led analysis, primary research, and real-world perspectives, delivered through clear outputs and interactive dashboards that provide meaningful, decision-ready insights.
From early clinical development through launch and lifecycle management, we provide intelligence that informs strategy at every stage of the product journey.
Build a clear understanding of disease landscapes, competitive dynamics, and pipeline evolution to support confident strategic and scientific decision-making.
We combine more than 30 years of competitive intelligence heritage with deep subject matter expertise across therapeutic areas to deliver intelligence that drives real competitive advantage.
Our approach is enhanced by AI-enabled technology, enabling us to synthesize complex data, scale insight generation, and deliver outputs that are faster, more consistent, and decision-ready.
Ongoing pipeline tracking, market evolution, and competitor activity monitoring. Real-time alerts and insight-led reporting to support timely decision-making.
Comprehensive medical congress coverage, delivering integrated clinical and commercial insight. Strategic interpretation of messaging, positioning, and emerging data.
Integrated disease, competitive, and pipeline landscape analysis. Strategic insight development, including stakeholder perspectives.
KOL, HCP, payer, and patient research to inform key decisions and strategy. Qualitative insights, patient journey mapping, stakeholder engagement, sentiment analysis, and advisory boards to inform communications and market strategy
Competitive simulation workshops to test strategy and anticipate competitor behavior. Strategic analysis to inform positioning, access, and lifecycle decisions.
Biosimilar and generics outlook and market landscape assessments by experts who understand the approval pathways and commercialization models specific to these product types.
Our senior team have 10–25+ years’ experience across pharma and biotech, with deep expertise in competitive intelligence, market dynamics, and strategic decision-making.
Contact us to learn how Competitive Intelligence can support your organization.
